Classification system proposed to guide the design, development, regulatory approval, and scaling of long acting, small- and macro-molecule parenteral products (CS-BLAP)
- 6 November 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (2) , 104056
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (U01AI148055)
- National Institutes of Health (R01 AI179309)
- National Institutes of Health (UM1 AI120176)
- National Institutes of Health (U01 HL152401)
- National Institutes of Health (33 AI149665)
- World Health Organization Centre for Health Development (2020-39-GLAD)
- Unitaid
- Office of AIDS Research (U01AI148055)
- Office of AIDS Research (UM1 AI120176)
This publication has 83 references indexed in Scilit:
- A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence AssessmentsClinical Pharmacology & Therapeutics, 2025
- Evaluation of model‐integrated evidence approaches for pharmacokinetic bioequivalence studies using model averaging methodsCPT: Pharmacometrics & Systems Pharmacology, 2024
- Model‐Informed Drug Development for Long‐Acting Injectable Products: Summary of American College of Clinical Pharmacology SymposiumClinical Pharmacology in Drug Development, 2021
- Use of Partial Area Under the Curve in Bioavailability or Bioequivalence Assessments: A Regulatory PerspectiveClinical Pharmacology & Therapeutics, 2021
- Emerging Research and Clinical Development Trends of Liposome and Lipid Nanoparticle Drug Delivery SystemsJournal of Pharmaceutical Sciences, 2014
- The Antibody Drug Absorption Following Subcutaneous or Intramuscular Administration and Its Mathematical Description by Coupling Physiologically Based Absorption Process with the Conventional Compartment Pharmacokinetic ModelThe Journal of Clinical Pharmacology, 2013
- The Role of BCS (Biopharmaceutics Classification System) and BDDCS (Biopharmaceutics Drug Disposition Classification System) in Drug DevelopmentJournal of Pharmaceutical Sciences, 2013
- Dermal Clearance Model for Epidermal Bioavailability CalculationsJournal of Pharmaceutical Sciences, 2012
- Lymphatic Transport of Proteins After Subcutaneous AdministrationJournal of Pharmaceutical Sciences, 2000
- Hindered transport of large molecules in liquid‐filled poresAIChE Journal, 1987